Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
35363452 | 0 | Devereaux PJ, Marcucci M, Painter TW, et al. Tranexamic Acid in Patients Undergoing Noncardiac Surgery. N Engl J Med. 2022 Apr 2. doi: 10.1056/NEJMoa2201171. | |
35362102 | 0 | Schulman S, Carlson V, Serrano PE, et al. Adherence to apixaban for extended thromboprophylaxis after major abdominal or pelvic surgery for cancer: A prospective cohort study. J Surg Oncol. 2022 Apr 1. doi: 10.1002/jso.26876. | |
34939141 | 0 | Bartoszko J, Li H, Fitzgerald J, et al. The association of thrombin generation with bleeding outcomes in cardiac surgery: a prospective observational study. Can J Anaesth. 2022 Mar;69(3):311-322. doi: 10.1007/s12630-021-02165-1. Epub 2021 Dec 22. | |
34852380 | 0 | Makedonov I, Kahn SR, Abdulrehman J, et al. Prevention of the post thrombotic syndrome with anticoagulation: a narrative review. Thromb Haemost. 2021 Dec 1. doi: 10.1055/a-1711-1263. | |
34556452 | 0 | Violette PD, Cartwright R, Devereaux PJ, et al. ARTS: A Large, International Trial of Thromboprophylaxis in Intra-abdominal, Gynecologic, and Urologic Surgery. Eur Urol Focus. 2021 Sep 21. pii: S2405-4569(21)00225-X. doi: 10.1016/j.euf.2021.08.010. | |
34351722 | 0 | Goligher EC, Bradbury CA, McVerry BJ, et al. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):777-789. doi: 10.1056/NEJMoa2103417. Epub 2021 Aug 4. | |
34351721 | 0 | Lawler PR, Goligher EC, Berger JS, et al. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26;385(9):790-802. doi: 10.1056/NEJMoa2105911. Epub 2021 Aug 4. | |
34334192 | 0 | Ho LTS, McVey MJ, Kuiper GJAJM, et al. Analysis of the effect of varying protamine-to-heparin ratio on coagulation in vitro. Br J Anaesth. 2021 Oct;127(4):e128-e130. doi: 10.1016/j.bja.2021.06.037. Epub 2021 Jul 30. | |
33872825 | 0 | Carlin S, Bond A, Gross P, et al. Initiation of anticoagulation in atrial fibrillation by primary care physicians: Results of a telephone survey. Thromb Res. 2021 Jun;202:176-181. doi: 10.1016/j.thromres.2021.04.004. Epub 2021 Apr 15. | |
33826233 | 0 | Juneja GK, Castelo M, Yeh CH, et al. Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: A single-center prospective longitudinal study. J Thromb Haemost. 2021 Jun;19(6):1546-1557. doi: 10.1111/jth.15327. Epub 2021 May 1. | |
33585495 | 0 | Gross PL, Chan NC. Thromboembolism in Older Adults. Front Med (Lausanne). 2021 Jan 27;7:470016. doi: 10.3389/fmed.2020.470016. eCollection 2020. | |
32815416 | 0 | Houston BL, Lawler PR, Goligher EC, et al. Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial. Clin Trials. 2020 Oct;17(5):491-500. doi: 10.1177/1740774520943846. Epub 2020 Aug 20. | |
32762455 | 0 | Siegal DM, Gross PL. Narrowing in on the True Rate of Venous Thromboembolism in Hospitalized Patients With COVID-19 Disease. Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):1958-1960. doi: 10.1161/ATVBAHA.120.314977. Epub 2020 Jul 30. | |
32506822 | 0 | Ni R, Neves MAD, Wu C, et al. Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates fibrin-dependent plasmin generation on thrombin-activated platelets. J Thromb Haemost. 2020 Sep;18(9):2364-2376. doi: 10.1111/jth.14950. | |
32133581 | 0 | Fitzgerald J, McMonnies R, Sharkey A, et al. Thrombin generation and bleeding in cardiac surgery: a clinical narrative review. Can J Anaesth. 2020 Jun;67(6):746-753. doi: 10.1007/s12630-020-01609-4. Epub 2020 Mar 4. | |
31380891 | 0 | Douketis JD, Spyropoulos AC, Duncan J, et al. Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Intern Med. 2019 Nov 1;179(11):1469-1478. doi: 10.1001/jamainternmed.2019.2431. | |
31005064 | 0 | Shaya SA, Gani DM, Weitz JI, et al. Factor XIII Prevents Pulmonary Emboli in Mice by Stabilizing Deep Vein Thrombi. Thromb Haemost. 2019 Jun;119(6):992-999. doi: 10.1055/s-0039-1685141. Epub 2019 Apr 20. | |
30985986 | 0 | Kim PY, Di Giuseppantonio LR, Wu C, et al. An assay to measure levels of factor Xa inhibitors in blood and plasma. J Thromb Haemost. 2019 Jul;17(7):1153-1159. doi: 10.1111/jth.14451. Epub 2019 May 10. | |
30760422 | 0 | Lee H, Tan MK, Yan AT, et al. Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial Fibrillation. Can J Cardiol. 2019 Feb;35(2):160-168. doi: 10.1016/j.cjca.2018.11.023. Epub 2018 Dec 3. | |
30511879 | 0 | Carrier M, Abou-Nassar K, Mallick R, et al. Apixaban to Prevent Venous Thromboembolism in Patients with Cancer. N Engl J Med. 2019 Feb 21;380(8):711-719. doi: 10.1056/NEJMoa1814468. Epub 2018 Dec 4. | |
30354213 | 0 | Ni R, Vaezzadeh N, Zhou J, et al. Effect of Different Doses of Acetylsalicylic Acid on the Antithrombotic Activity of Clopidogrel in a Mouse Arterial Thrombosis Model. Arterioscler Thromb Vasc Biol. 2018 Oct;38(10):2338-2344. doi: 10.1161/ATVBAHA.118.311404. | |
29564837 | 0 | Schulman S, Gross PL, Ritchie B, et al. Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study. Thromb Haemost. 2018 May;118(5):842-851. doi: 10.1055/s-0038-1636541. Epub 2018 Mar 21. | |
29466159 | 0 | Anderson DR, Dunbar M, Murnaghan J, et al. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty. N Engl J Med. 2018 Feb 22;378(8):699-707. doi: 10.1056/NEJMoa1712746. | |
29353682 | 0 | van Es N, Louzada M, Carrier M, et al. Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study. Thromb Res. 2018 Mar;163:41-46. doi: 10.1016/j.thromres.2018.01.009. Epub 2018 Jan 9. | |
29212129 | 0 | Douketis JD, Spyropoulos AC, Anderson JM, et al. The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale. Thromb Haemost. 2017 Dec;117(12):2415-2424. doi: 10.1160/TH17-08-0553. Epub 2017 Dec 6. | |
28894738 | 0 | Smrke A, Gross PL. Cancer-Associated Venous Thromboembolism: A Practical Review Beyond Low-Molecular-Weight Heparins. Front Med (Lausanne). 2017 Aug 28;4:142. doi: 10.3389/fmed.2017.00142. eCollection 2017. | |
27780803 | 0 | Fredenburgh JC, Gross PL, Weitz JI. Emerging anticoagulant strategies. Blood. 2017 Jan 12;129(2):147-154. doi: 10.1182/blood-2016-09-692996. Epub 2016 Oct 25. | |
27126647 | 0 | Jagadeeswaran P, Cooley BC, Gross PL, et al. Animal Models of Thrombosis From Zebrafish to Nonhuman Primates: Use in the Elucidation of New Pathologic Pathways and the Development of Antithrombotic Drugs. Circ Res. 2016 Apr 29;118(9):1363-79. doi: 10.1161/CIRCRESAHA.115.306823. | |
26879070 | 0 | Bell AD, Gross P, Heffernan M, et al. Appropriate Use of Antithrombotic Medication in Canadian Patients With Nonvalvular Atrial Fibrillation. Am J Cardiol. 2016 Apr 1;117(7):1107-11. doi: 10.1016/j.amjcard.2015.12.055. Epub 2016 Jan 14. | |
25727083 | 0 | Patel AD, Tan MK, Angaran P, et al. Risk stratification and stroke prevention therapy care gaps in Canadian atrial fibrillation patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation chart audit). Am J Cardiol. 2015 Mar 1;115(5):641-6. doi: 10.1016/j.amjcard.2014.12.022. Epub 2014 Dec 18. | |
25691157 | 0 | Vu TT, Zhou J, Leslie BA, et al. Arterial thrombosis is accelerated in mice deficient in histidine-rich glycoprotein. Blood. 2015 Apr 23;125(17):2712-9. doi: 10.1182/blood-2014-11-611319. Epub 2015 Feb 17. |